Erlotinib Hydrochloride
NDC 72205-081, Erlotinib Hydrochloride, tablet, film coated, from Novadoz Pharmaceuticals LLC.
- Product NDC
- 72205-081
- Status
- Listed
- Labeler
- Novadoz Pharmaceuticals LLC
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA214366
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/72205-081 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ERLOTINIB HYDROCHLORIDE100 mg/1
Pharmacologic classes
Kinase Inhibitor [EPC]; Protein Kinase Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 72205-081-30 | 72205008130 | 1 BOTTLE in 1 CARTON (72205-081-30) / 30 TABLET, FILM COATED in 1 BOTTLE |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/4cff04f5-3693-4d87-a9f8-a2b195e3d26e
Use it
Look up 72205-081 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/72205-081 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 72205-081. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.